Predictive toxicity

Fluofarma's innovative technology brings high throughput to in vivo predictive toxicity analysis.

Services for toxicity testing

Our predictive technology can be used to test toxicity at an early stage in a drug's development and enables pharmaceutical companies to obtain their compounds' ecotoxicity, cytotoxicity and genotoxicity profiles using a single method.

Cytotoxicity

Study of cell membrane integrity
Apoptosis
Cytolysis
Oxidative stress
Mitochondrial function
Cell proliferation… 

Genotoxicity

Quantification of DNA damages
Quantification of DNA repair
Micronuclei analysis 

Download Toxicity.pdf

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Biochimica et Biophysica Acta - Molecular Cell Research.

    Read more [+]

  • IFSCC 2008

    Fluofarma will be attending IFSCC 2008, in Barcelona, from October 6th to 9th.

    Read more [+]

  • INVITOX 2008

    Fluofarma will be attending the INVITOX 2008 meeting, in Stockholm from September 25th to 28th.

    Read more [+]

  • EuroBio 2008

    Fluofarma will be attending EuroBio 2008, in Paris from October 7th to 9th.

    Read more [+]

  • SMi's Cell-Based Assays 2008

    Fluofarma will be attending SMi's Cell-Based Assays conference, in London from November 19th to 20th.

    Read more [+]

  • GDDI Forum 2009

    Fluofarma will be attending Global Discovery & Development Innovation Forum 2009, in London, from March 2nd to 3rd.

    Read more [+]

FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to compare and profile your anti-cancer drugs. Read more [+]